Transcription factor Maf also known as proto-oncogene c-Maf or V-maf musculoaponeurotic fibrosarcoma oncogene homolog is a
transcription factor that in humans is encoded by the MAFgene.[5][6]
Kerppola TK, Curran T (Mar 1994). "Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun". Oncogene. 9 (3): 675–84.
PMID8108109.
Kurschner C, Morgan JI (Feb 1997). "USF2/FIP associates with the b-Zip transcription factor, c-Maf, via its bHLH domain and inhibits c-Maf DNA binding activity". Biochemical and Biophysical Research Communications. 231 (2): 333–9.
doi:
10.1006/bbrc.1997.6097.
PMID9070273.
Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM (Jun 1998). "Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma". Blood. 91 (12): 4457–63.
doi:
10.1182/blood.V91.12.4457.
PMID9616139.
S2CID14835515.
Vanita V, Singh D, Robinson PN, Sperling K, Singh JR (Mar 2006). "A novel mutation in the DNA-binding domain of MAF at 16q23.1 associated with autosomal dominant "cerulean cataract" in an Indian family". American Journal of Medical Genetics Part A. 140 (6): 558–66.
doi:
10.1002/ajmg.a.31126.
PMID16470690.
S2CID13734492.
Transcription factor Maf also known as proto-oncogene c-Maf or V-maf musculoaponeurotic fibrosarcoma oncogene homolog is a
transcription factor that in humans is encoded by the MAFgene.[5][6]
Kerppola TK, Curran T (Mar 1994). "Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun". Oncogene. 9 (3): 675–84.
PMID8108109.
Kurschner C, Morgan JI (Feb 1997). "USF2/FIP associates with the b-Zip transcription factor, c-Maf, via its bHLH domain and inhibits c-Maf DNA binding activity". Biochemical and Biophysical Research Communications. 231 (2): 333–9.
doi:
10.1006/bbrc.1997.6097.
PMID9070273.
Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM (Jun 1998). "Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma". Blood. 91 (12): 4457–63.
doi:
10.1182/blood.V91.12.4457.
PMID9616139.
S2CID14835515.
Vanita V, Singh D, Robinson PN, Sperling K, Singh JR (Mar 2006). "A novel mutation in the DNA-binding domain of MAF at 16q23.1 associated with autosomal dominant "cerulean cataract" in an Indian family". American Journal of Medical Genetics Part A. 140 (6): 558–66.
doi:
10.1002/ajmg.a.31126.
PMID16470690.
S2CID13734492.